Bonesupport Holding Ab Stock Fundamentals
| BOEUF Stock | USD 32.16 0.12 0.37% |
Bonesupport Holding AB fundamentals help investors to digest information that contributes to Bonesupport Holding's financial success or failures. It also enables traders to predict the movement of Bonesupport Pink Sheet. The fundamental analysis module provides a way to measure Bonesupport Holding's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bonesupport Holding pink sheet.
Bonesupport |
Bonesupport Holding AB Company Current Valuation Analysis
Bonesupport Holding's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Bonesupport Holding Current Valuation | 511.7 M |
Most of Bonesupport Holding's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bonesupport Holding AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Bonesupport Holding AB has a Current Valuation of 511.7 M. This is 96.44% lower than that of the Healthcare sector and 94.4% lower than that of the Medical Instruments & Supplies industry. The current valuation for all United States stocks is 96.92% higher than that of the company.
Bonesupport Holding Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Bonesupport Holding's current stock value. Our valuation model uses many indicators to compare Bonesupport Holding value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bonesupport Holding competition to find correlations between indicators driving Bonesupport Holding's intrinsic value. More Info.Bonesupport Holding AB is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bonesupport Holding's earnings, one of the primary drivers of an investment's value.Bonesupport Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bonesupport Holding's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Bonesupport Holding could also be used in its relative valuation, which is a method of valuing Bonesupport Holding by comparing valuation metrics of similar companies.Bonesupport Holding is currently under evaluation in current valuation category among its peers.
Bonesupport Fundamentals
| Return On Equity | -0.25 | |||
| Return On Asset | -0.13 | |||
| Profit Margin | (0.25) % | |||
| Current Valuation | 511.7 M | |||
| Shares Outstanding | 64.55 M | |||
| Shares Owned By Insiders | 12.79 % | |||
| Shares Owned By Institutions | 53.83 % | |||
| Price To Book | 16.68 X | |||
| Price To Sales | 15.22 X | |||
| Revenue | 212.88 M | |||
| Gross Profit | 189.7 M | |||
| EBITDA | (72.39 M) | |||
| Net Income | (85.53 M) | |||
| Debt To Equity | 0.08 % | |||
| Current Ratio | 4.59 X | |||
| Cash Flow From Operations | (83.42 M) | |||
| Number Of Employees | 92 | |||
| Beta | 1.09 | |||
| Market Capitalization | 466.27 M | |||
| Total Asset | 343.92 M | |||
| Net Asset | 343.92 M |
About Bonesupport Holding Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bonesupport Holding AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bonesupport Holding using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bonesupport Holding AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Bonesupport Holding AB , an orthobiologics company, develops and commercializes injectable bioceramic bone graft substitutes for the treatment of bone voids in Europe, North America, and internationally. The company was founded in 1999 and is headquartered in Lund, Sweden. Bonesupport Holding is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Other Information on Investing in Bonesupport Pink Sheet
Bonesupport Holding financial ratios help investors to determine whether Bonesupport Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bonesupport with respect to the benefits of owning Bonesupport Holding security.